APBC in Groningen - from research to practice

How do university research findings make their way into practice? This was one of the questions we discussed when researchers from the APBC project met on 9 and 10 November 2026 at the University of Groningen in the Netherlands. Alongside the Project Management Board (PMB) meeting, we visited the Molecular Enzymology laboratories and heard how a biotechnology company grew out of university research.
The meeting brought together representatives from Pavol Jozef Šafárik University in Košice (UPJS), the Institute of Neuroimmunology of the Slovak Academy of Sciences in Bratislava (INSAS), the Institute of Experimental Physics of the Slovak Academy of Sciences in Košice (IEP), the University of Bayreuth (UBT), Masaryk University in Brno and our host, the University of Groningen (UG). Colleagues from JUHAPHARM represented the private sector in person. Other researchers from UPJS, IEP and UBT joined online, as did a representative from Enantis. UPJS, the project coordinator, had the largest group in Groningen. It included colleagues from the Center for Interdisciplinary Biosciences at the Technology and Innovation Park of UPJS and the Faculty of Science at UPJS.
Prof. Erik Sedlák (UPJS), the project’s principal investigator, reviewed progress after 20 months and presented the results achieved so far. By the time of the meeting, four of the five project milestones had been reached. Seventeen scientific papers had been published with APBC support, eight of them co-authored by consortium partners. One priority for the remaining months is to establish the Mass Photometry Centre at UPJS. The instrument is already operational, and the first measurements have been carried out. The Board also discussed how to support early-stage start-ups and further involve industry partners in the project. The discussion focused on how agreements with companies can lead to concrete joint activities. We also talked about how companies can share their experience with students and early-career researchers to help them develop ideas with practical applications.
During our visit, Prof. Marco Fraaije (UG) told us about the university’s history, how it operates today and its current priorities. Together with his PhD student X. Fan, he also presented the work of his Molecular Enzymology group. In the Feringa Building, we toured the university facilities and the group’s laboratories. Dr. Engel Vrieling, Managing Director of the Groningen Biomolecular Sciences and Biotechnology Institute at the University of Groningen, explained how the institute organises research and doctoral training. We also visited GECCO Biotech, which Prof. Fraaije co-founded and where he serves as Chief Scientific Officer. He told us how the company started, how it operates today and how it works with the university. He also gave specific examples of how findings from enzyme research can be applied in industry.
The laboratory and company visits sparked a lively discussion. We were interested in how research groups are supported and what helps early-stage companies grow. We also discussed some of the specific questions we encounter in our own protein research. The following day, a guided tour of the University Museum gave us a chance to learn more about the university’s history.
Our warmest thanks go to Professor Marco Fraaije for welcoming us and for putting together the entire programme. Thanks to his thoughtful organisation, we covered a great deal in two days and still had plenty of time for questions, informal conversations and sharing experiences.
The next PMB meeting is planned for 2027 in Bayreuth in Germany. We are already looking forward to meeting in person again and continuing the conversations we started in Groningen. It will also be a chance to get to know another leading European university.
The meeting was supported by the APBC project (09I02-03-V01-00021), funded by the European Union under the NextGenerationEU initiative through the Recovery and Resilience Plan of the Slovak Republic.

